• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）。
Semin Hematol. 2022 Apr;59(2):57-58. doi: 10.1053/j.seminhematol.2022.03.004. Epub 2022 Mar 8.
2
The psychiatric and psychological sequelae of vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）的精神和心理后遗症。
Semin Hematol. 2022 Apr;59(2):115-119. doi: 10.1053/j.seminhematol.2022.02.003. Epub 2022 Feb 18.
3
"Vaccine-induced immune thrombotic thrombocytopenia (VITT)-Update on diagnosis and management considering different resources": Comment.“疫苗诱导的免疫性血栓性血小板减少症（VITT）——考虑不同资源的诊断和管理最新进展”：评论
J Thromb Haemost. 2022 Nov;20(11):2707-2708. doi: 10.1111/jth.15853.
4
VITT with inactivated SARS-CoV-2 vaccine - index case.接种过灭活 SARS-CoV-2 疫苗的 VITT - 首例病例。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2036556. doi: 10.1080/21645515.2022.2036556. Epub 2022 Mar 7.
5
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.疑似 COVID-19 疫苗诱导（免疫性）血栓性血小板减少症的实验室检测。
Int J Lab Hematol. 2021 Aug;43(4):559-570. doi: 10.1111/ijlh.13629. Epub 2021 Jun 17.
6
The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症的起伏变化
Lancet Haematol. 2022 Apr;9(4):e246. doi: 10.1016/S2352-3026(22)00078-3.
7
An idiotypic network dysregulation could be related to the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT) following vaccination with vaccines expressing Spike protein of SARS CoV2.独特型网络失调可能与接种表达 SARS-CoV-2 刺突蛋白的疫苗后发生的疫苗诱导的免疫性血栓性血小板减少症（VITT）的发病机制有关。
Intern Emerg Med. 2022 Jun;17(4):1249-1250. doi: 10.1007/s11739-022-02956-4. Epub 2022 Mar 6.
8
Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody.疫苗诱导的免疫性血栓性血小板减少症由一种刻板的克隆型抗体介导。
Blood. 2022 Oct 13;140(15):1738-1742. doi: 10.1182/blood.2022016474.
9
Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia.艾曲泊帕用于难治性疫苗诱导的免疫性血栓性血小板减少症。
J Thromb Thrombolysis. 2022 May;53(4):954-958. doi: 10.1007/s11239-021-02604-2. Epub 2021 Nov 19.
10
Laboratory testing for VITT antibodies.针对 VITT 抗体的实验室检测。
Semin Hematol. 2022 Apr;59(2):80-88. doi: 10.1053/j.seminhematol.2022.03.003. Epub 2022 Mar 7.

引用本文的文献

1
Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan.比较在约旦接种信使 RNA(messenger RNA, mRNA)疫苗和常规 COVID-19 疫苗的 T 细胞介导免疫反应和副作用。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2333104. doi: 10.1080/21645515.2024.2333104. Epub 2024 Apr 7.
2
Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.疫苗诱导的免疫性血栓性血小板减少症的独特特征；一种新的抗血小板因子 4 抗体介导的疾病。
Int J Hematol. 2023 Mar;117(3):341-348. doi: 10.1007/s12185-022-03516-4. Epub 2022 Dec 27.
3
Safety of COVID-19 Vaccines: Spotlight on Neurological Complications.新冠疫苗的安全性：聚焦神经并发症
Life (Basel). 2022 Aug 29;12(9):1338. doi: 10.3390/life12091338.
4
Protein-based vaccine as the booster dose for adults: evidence and beyond.基于蛋白质的疫苗作为成人加强针：证据及其他。
Lancet Infect Dis. 2022 Nov;22(11):1515-1517. doi: 10.1016/S1473-3099(22)00447-9. Epub 2022 Aug 10.
5
Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）的发病机制。
Semin Hematol. 2022 Apr;59(2):97-107. doi: 10.1053/j.seminhematol.2022.02.004. Epub 2022 Feb 23.
6
Focusing Treatment on Pregnant Women With COVID Disease.将治疗重点放在患有新冠疾病的孕妇身上。
Front Glob Womens Health. 2021 Oct 11;2:590945. doi: 10.3389/fgwh.2021.590945. eCollection 2021.

Vaccine-induced immune thrombotic thrombocytopenia (VITT).

作者信息

Warkentin Theodore E

机构信息

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Transfusion Medicine, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada; Service of Benign Hematology, Hamilton Health Sciences, Hamilton General Hospital, Hamilton, Ontario, Canada; McMaster Center for Transfusion Research, McMaster University, Hamilton, Ontario, Canada; McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario.

出版信息

Semin Hematol. 2022 Apr;59(2):57-58. doi: 10.1053/j.seminhematol.2022.03.004. Epub 2022 Mar 8.

DOI:10.1053/j.seminhematol.2022.03.004
PMID:35512901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8902053/
Abstract
摘要